Publication
2/01/2016
Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
Gurda BL, De Guilhem De Lataillade A, Bell P, Zhu Y, Yu H, Wang P, Bagel J, Vite CH, Sikora T, Hinderer C, Calcedo R, Yox AD, Steet RA, Ruane T, O'Donnell P, Gao G, Wilson JM, Casal M, Ponder KP, Haskins ME
Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Publication
8/01/2015
Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates.
Hinderer C, Bell P, Louboutin JP, Zhu Y, Yu H, Lin G, Choa R, Gurda BL, Bagel J, O'Donnell P, Sikora T, Ruane T, Wang P, Tarantal AF, Casal ML, Haskins ME, Wilson JM
Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Publication
12/01/2014
Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I.
Hinderer C, Bell P, Gurda BL, Wang Q, Louboutin JP, Zhu Y, Bagel J, O'Donnell P, Sikora T, Ruane T, Wang P, Haskins ME, Wilson JM
Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Publication
10/14/2014
Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I.
Hinderer C, Bell P, Gurda BL, Wang Q, Louboutin JP, Zhu Y, Bagel J, O'Donnell P, Sikora T, Ruane T, Wang P, Haskins ME, Wilson JM
Proceedings Of The National Academy Of Sciences Of The United States Of America
